Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast
Yahoo Finance · 4 days ago
Open | 49.06 |
High | 49.31 |
Low | 47.85 |
Mkt Cap | 97.81B |
P/E (TTM) | N/A |
Div & Yield | 2.40 & 4.90% |
Prev. Close | 48.98 |
52 Wk. Low | 39.35 |
52 Wk. High | 63.41 |
Related stocks
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 12.2B | 8.70% ▲ |
Net Income | 1.68B | 19.00% ▼ |
Diluted EPS | 2.07 | 16.30% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $1.60 | - |
Q2 2024 | $1.63 | $2.07 |
Q1 2024 | -$4.44 | -$4.40 |
S&P 500^GSPC | 5,437.58-25.96 (-0.48%) |
Dow 30^DJI | 40,593.11+53.18 (+0.13%) |
Nasdaq^IXIC | 17,197.19-173.01 (-1.00%) |
63.20+7.23% | |
7.17-2.19% | |
233.40-9.82% |